全文获取类型
收费全文 | 2832篇 |
免费 | 264篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 194篇 |
妇产科学 | 51篇 |
基础医学 | 456篇 |
口腔科学 | 116篇 |
临床医学 | 225篇 |
内科学 | 629篇 |
皮肤病学 | 57篇 |
神经病学 | 102篇 |
特种医学 | 204篇 |
外科学 | 344篇 |
综合类 | 39篇 |
预防医学 | 160篇 |
眼科学 | 45篇 |
药学 | 198篇 |
中国医学 | 4篇 |
肿瘤学 | 290篇 |
出版年
2023年 | 22篇 |
2022年 | 20篇 |
2021年 | 31篇 |
2020年 | 22篇 |
2019年 | 32篇 |
2018年 | 68篇 |
2017年 | 72篇 |
2016年 | 61篇 |
2015年 | 85篇 |
2014年 | 110篇 |
2013年 | 145篇 |
2012年 | 114篇 |
2011年 | 96篇 |
2010年 | 109篇 |
2009年 | 140篇 |
2008年 | 99篇 |
2007年 | 125篇 |
2006年 | 107篇 |
2005年 | 90篇 |
2004年 | 98篇 |
2003年 | 64篇 |
2002年 | 71篇 |
2001年 | 50篇 |
2000年 | 65篇 |
1999年 | 54篇 |
1998年 | 119篇 |
1997年 | 93篇 |
1996年 | 109篇 |
1995年 | 80篇 |
1994年 | 87篇 |
1993年 | 54篇 |
1992年 | 53篇 |
1991年 | 45篇 |
1990年 | 42篇 |
1989年 | 62篇 |
1988年 | 53篇 |
1987年 | 47篇 |
1986年 | 55篇 |
1985年 | 34篇 |
1984年 | 29篇 |
1983年 | 16篇 |
1982年 | 28篇 |
1981年 | 18篇 |
1980年 | 27篇 |
1979年 | 17篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1976年 | 16篇 |
1975年 | 17篇 |
1969年 | 9篇 |
排序方式: 共有3128条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
In two previous studies, we observed that recombinant human interleukin- 3 (IL-3) induced an increase in marrow burst-forming unit-erythroid- derived colonies in vitro in some patients with Diamond-Blackfan anemia (DBA). To determine whether a similar erythropoietic response could be induced in vivo, we treated 13 patients with DBA (aged 4 to 19 years) with two preparations of IL-3. All patients had absent absolute reticulocyte counts and markedly reduced to absent recognizable bone marrow erythroid elements; patients with circulating reticulocytes in the previous 12 months were excluded from study. All patients except 1 had failed steroid therapy and had been transfusion-dependent since infancy; 1 patient was maintained on high-dose prednisone at the time of enrollment. On the first arm of the study, IL-3 (Immunex Corp, Seattle, WA) was administered subcutaneously using a dose escalation regimen of 125 to 500 micrograms/m2/day in divided dosage at 12-hour intervals, coadministered with 1.5 mg/kg/d of oral ferrous sulphate. Of the 13 patients that entered the trial, 4 stopped prematurely because of adverse side effects. In the other 9 evaluable cases, reticulocytes increased transiently in 1 patient from 0 to 65 x 10(9)/L after 35 days of IL-3 therapy at 250 micrograms/m2, but transfusion dependency persisted. One transient peak in absolute reticulocyte count was noted in 6 other patients, but no erythroid response was observed after completion of a full course of IL-3. Oral prednisone at 0.5 mg/kg/d was then coadministered with IL-3 at 500 micrograms/m2 to 5 of the patients without effect, and treatment was stopped. In 2 patients, a second preparation of IL-3 (Sandoz Canada Inc, Dorval, Quebec, Canada) was initiated in a dose escalation regimen of 2.5 to 10 micrograms/kg and was coadministered with ferrous sulphate. No erythroid response was observed in either patient, and in one of the two, alternate-day subcutaneous recombinant erythropoietin at 300 U/kg was administered for 3 weeks in combination with daily IL-3 at 10 micrograms/kg, but no increased erythropoiesis was seen. Significant increases in white blood cell and eosinophil counts during administration of both preparations of IL-3 were observed in all patients. These data show that the response of DBA patients to IL-3 in vivo is heterogeneous and cannot be predicted from in vitro studies. The absence of a corrective effect of IL-3 in these patients with DBA indicates that a deficiency of the cytokine is not central in the pathogenesis of the disorder. 相似文献
85.
L. Testai S. Rapposelli A. Martelli M.C. Breschi V. Calderone 《Medicinal research reviews》2015,35(3):520-553
Brief periods of ischemia are known to confer to the myocardium an increased resistance to the injury due to a later and more prolonged ischemic episode. This phenomenon, known as ischemic preconditioning (IPreC), is ensured by different biological mechanisms. Although an exhaustive comprehension of them has not been reached yet, it is widely accepted that mitochondria are pivotally involved in controlling cell life and death, and thus in IPreC. Among the several signaling pathways involved, as triggers and/or end effectors, in the mitochondrial mechanisms of cardioprotection, an important role is played by the activation of potassium channels located in the mitochondrial inner membrane (mitoK) of cardiomyocytes. Presently, different types of mitoK channels have been recognized in the heart, such as ATP‐sensitive (mitoKATP) and calcium‐activated (mitoBKCa and mitoSKCa) potassium channels. Consistently, drugs modulating mitoK, on one hand, have been employed as useful experimental tools for early basic studies on IPreC. On the other hand, activators of mitoK are promising and innovative therapeutic agents for limiting the myocardial injury due to ischemic episodes. In this review, we report the experimental evidence supporting the role of mitoK in signaling pathways in the mechanisms of cardioprotection and an overview on the most important molecules acting as modulators of these channels, with their profiles of selectivity. Some innovative pharmaceutical strategies for mitochondriotropic drugs have been also reported. Finally, an appendix describing the main experimental approaches usually employed to study mitoK in isolated mitochondria or in intact cells has been added. 相似文献
86.
Flora Maria Lorenzo Fortes Ney Boa Sorte Victor D Mariano La la D Andrade Fernanda A Oliveira Monique CA Santos Cl udia Ivanilda N dos Santos Catharina A Passos Mila P Pacheco Valdiana C Surlo Neog lia P de Almeida Jaciane AM Fontes r a M Pimentel Raquel Rocha Genoile Oliveira Santana 《World journal of gastroenterology : WJG》2020,26(44):6993-7004
BACKGROUNDThere has been an increase in cases of inflammatory bowel disease (IBD) in recent years. There is also greater access and availability of immunosuppressive and biological agents, which increase the risk of opportunistic infection despite improving the quality of life and promoting mucosal healing. Tuberculosis (TB) remains a public health problem, and it has a high incidence in several countries. Therefore, knowledge of the risk of developing TB in patients with IBD is important.AIMTo evaluate the risk of active TB in patients with IBD under treatment from an endemic area in Latin America.METHODSA standard questionnaire included demographic variables, clinical aspects of IBD disease, history of active TB during treatment, active TB characteristics and evolution, initial screening and results and time from the start of anti-tumor necrosis factor alpha (TNFα) to TB development.RESULTSAzathioprine, anti-TNFα and the combination of these two drugs were associated with a higher risk of active TB incidence. The TNFα blockers increased the relative risk of developing active TB compared to other treatments. All four multivariable models showed that the use of TNFα blockers alone or in combination with azathioprine was an important risk factor for the incidence of active TB. After adjustment for sex, age, type of IBD and latent TB, anti-TNFα with azathioprine increased the relative risk to 17.8 times more than conventional treatment. Late TB, which was diagnosed 3 mo after the start of anti-TNFα, was the most frequent.CONCLUSIONTreatment with anti-TNFα increased the risk of active TB in IBD patients from an endemic area in Latin America. This risk was increased when anti-TNFα was combined with azathioprine. The time from the beginning of the treatment to the active TB diagnosis suggests a new TB infection. 相似文献
87.
Antonello Fadda Antonio Di Renzo Francesco Martelli Dario Marangoni Anna Paola Batocchi Daniela Giannini Vincenzo Parisi Benedetto Falsini 《Clinical neurophysiology》2013,124(8):1652-1658
ObjectiveSustained pattern stimulation in normal subjects induces adaptive changes in pattern electroretinogram (PERG), an effect that has been interpreted as a response of glial cells and retinal ganglion cells (RGC). The aim of this study was to compare the effect in normal subjects and in multiple sclerosis patients without previous optic neuritis.MethodsPERGs were elicited by a 7.5 Hz pattern stimulus, presented continuously over 152 s. Response cycles were averaged in 20 packets of 60 events each and amplitude and phase of the 2nd harmonic response was measured. Adaptive changes are expressed as amplitude reduction over the full examination time.ResultsIn normal subjects PERG amplitude declined progressively to a plateau (dA = ?0.46 μV, SE = 0.09 μV); in patients the effect size was severely reduced (dA = ?0.20 μV, SE = 0.04 μV). No significant difference was found in mean amplitude.ConclusionsThe results show reduced RGC habituation in patients, suggesting an abnormal gain and sensitivity control in the inner retina, even in absence of clinical optic neuritis. Recent findings in astrocyte biology and indications drawn from a mathematical model point to a key role of glial cells in this process.SignificanceThe proposed methodology may have implications in the assessment of MS patients and in understanding the pathophysiology of neurological and retinal disorders. 相似文献
88.
Elizabete Bagordakis Lívia Máris Ribeiro Paranaiba Luciano Abreu Brito Sibele Nascimento de Aquino Ana Camila Messetti Hercílio Martelli‐Junior Mario Sergio Oliveira Swerts Edgard Graner Maria Rita Passos‐Bueno Ricardo D. Coletta DDS MS PhD 《American journal of medical genetics. Part A》2013,161(5):1177-1180
89.
Abstract: The prevalence of Parkinson’s disease (PD) is expected to double over the next 20 years owing to the increase in life expectancy. This progressive disease has several implications relating to oral health, and many are manageable with proper awareness and knowledge about the disease. This article reviews the epidemiology, pathophysiology, and characteristics of PD, as well as the treatments and oral health considerations to enable dental hygienists to undertake an informed approach to patient management strategies and provide optimal care. 相似文献
90.